Supplement use during an intergroup clinical trial for breast cancer (S0221)

The use of supplements during chemotherapy is controversial, partly due to the potential effect of antioxidants on reduced efficacy of chemotherapy-related cytotoxicity. We examined supplement use among breast cancer patients registered to a clinical trial (SWOG 0221) before diagnosis and during tre...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Zirpoli, Gary R., Brennan, Patrick M., Hong, Chi-Chen, McCann, Susan E., Ciupak, Gregory, Davis, Warren, Unger, Joseph M., Thomas Budd, G., Hershman, Dawn L., Moore, Halle C.F., Stewart, James, Isaacs, Claudine, Hobday, Timothy, Salim, Muhammad, Hortobagyi, Gabriel N., Gralow, Julie R., Albain, Kathy S., Ambrosone, Christine B.
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2013
Teme:
Epidemiology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3552360/
https://ncbi.nlm.nih.gov/pubmed/23306462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-012-2400-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items